Budralazine
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
N-(4-methylpent-3-en-2-ylideneamino)phthalazin-1-amine
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 36798-79-5 |
| ATC code | none |
| PubChem | CID: 6419536 |
| ChemSpider | 4925205 |
| UNII | S0177QHV2B  |
| ChEMBL | CHEMBL2107516 |
| Chemical data | |
| Formula | C14H16N4 |
| Molecular mass | 240.30 g/mol |
|
|
Budralazine (INN) is a vasodilator.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Phthalazines
- Hydrazines
- Cardiovascular system drug stubs
